Adverum Biotechnologies, Inc. (ADVM)

Adverum Biotechnologies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	96	97	76	58	173	1,057
Market Cap Growth	-19.52%	27.47%	31.53%	-66.46%	-83.63%	36.33%
Enterprise Value	159.14	63.37	53.89	-20.72	-29.04	658.41
Last Close Price	4.36	4.67	7.53	5.80	17.60	108.40
PS Ratio	-	97.36	21.22	-	23.09	-
PB Ratio	-	1.38	1.14	0.32	0.55	2.43
P/TBV Ratio	-1.69	1.31	1.13	0.32	0.55	2.13
EV/Sales Ratio	-	63.37	14.97	-	-3.87	-
EV/EBITDA Ratio	-	-	-	0.14	0.21	-
EV/EBIT Ratio	-	-	-	0.13	0.20	-
EV/FCF Ratio	-	-	-	0.17	0.24	-
Debt / Equity Ratio	-1.60	1.30	1.10	0.59	0.33	0.07
Asset Turnover	-	0.01	0.02	0	0.02	0
Quick Ratio	0.58	5.49	4.83	5.76	14.58	20.59
Current Ratio	0.65	5.73	5.14	5.91	14.88	20.82
Return on Equity (ROE)	-2453.93%	-189.84%	-98.19%	-62.10%	-38.78%	-38.57%
Return on Assets (ROA)	-149.63%	-82.93%	-55.56%	-42.01%	-31.69%	-33.77%
Return on Invested Capital (ROIC)	-364.62%	-247.00%	-136.09%	-123.01%	-165.04%	-230.12%
Return on Capital Employed (ROCE)	-204.47%	-95.08%	-62.61%	-45.25%	-33.21%	-35.47%
Buyback Yield / Dilution	-26.37%	-96.21%	-1.58%	-1.24%	-15.14%	-32.83%
Total Shareholder Return	-26.37%	-96.21%	-1.58%	-1.24%	-15.14%	-32.83%

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q